Financials
- Market Capitalization 102.68 M
- Employee 220
- Founded 2002
- CEO N/A
- Website www.exagen.com
- Headquarter Delaware, United States
- FIGI BBG00178FZY1
- Industry Diagnostics & Research
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3814 | IMDX Insight Molecular Diagnostics Inc. - Common Stock | 4.71 USD | +5.61% | +1.51% | -17.37% | +65.26% | 152.09 M USD | ||
| 3874 | STIM Neuronetics, Inc. - Common Stock | 1.91 USD | +7.91% | +28.19% | +50.39% | -48.79% | 132.91 M USD | ||
| 4010 | BNR Burning Rock Biotech Limited - American Depositary Shares | 9.80 USD | 0.00% | -16.10% | +7.93% | -67.25% | 106.04 M USD | ||
| 4298 | DRIO DarioHealth Corp. - Common Stock | 7.29 USD | +11.64% | +0.55% | +5.50% | -34.74% | 53.31 M USD |
Frequently asked questions about Exagen Inc. - Common Stock
What is the Exagen Inc. - Common Stock stock price today?
The current price of Exagen Inc. - Common Stock (XGN) is 4.25. Over the past 24 hours, the stock has changed by +3.91%. Follow the XGN chart for real-time price dynamics.
What is the stock ticker of Exagen Inc. - Common Stock?
Exagen Inc. - Common Stock trades under the ticker XGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Exagen Inc. - Common Stock stock going up?
XGN has changed by -3.19% over the last week, -7.81% over the last month, and -37.77% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Exagen Inc. - Common Stock net income for the last quarter?
Exagen Inc. - Common Stock reported net income of -3.97 M for the last quarter. The previous quarter showed -4.67 M, which means net income changed by +15.11%.
How many employees does Exagen Inc. - Common Stock have?
As of the latest available data, Exagen Inc. - Common Stock has 220 employees. Workforce size can provide additional context about the company's scale and operations.
What is Exagen Inc. - Common Stock EBITDA?
Exagen Inc. - Common Stock EBITDA is 4.29 M, and its EBITDA margin is 24.77%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Exagen Inc. - Common Stock stock?
You can buy Exagen Inc. - Common Stock (XGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Exagen Inc. - Common Stock stock?
Investing in Exagen Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XGN chart and related analysis on metatrader.com as part of your research.